Total Payments
$2,825
2023 Payments
$21.35
Companies
25
Transactions
187
Medicare Patients
2,197
Medicare Billing
$229,277
Payment Breakdown by Category
Food & Beverage$2,825 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,825 | 187 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $469.73 | 33 | $0 (2023) |
| AstraZeneca Pharmaceuticals LP | $364.78 | 25 | $0 (2020) |
| Merck Sharp & Dohme Corporation | $331.66 | 24 | $0 (2020) |
| Amgen Inc. | $249.65 | 14 | $0 (2021) |
| Radius Health, Inc. | $238.88 | 12 | $0 (2019) |
| Janssen Pharmaceuticals, Inc | $224.85 | 12 | $0 (2020) |
| Allergan, Inc. | $130.94 | 10 | $0 (2020) |
| Novartis Pharmaceuticals Corporation | $124.03 | 8 | $0 (2020) |
| Lilly USA, LLC | $108.29 | 9 | $0 (2021) |
| AbbVie Inc. | $106.36 | 7 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $21.35 | 1 | Novo Nordisk Inc ($21.35) |
| 2022 | $112.56 | 6 | iRhythm Technologies, Inc. ($49.65) |
| 2021 | $78.27 | 5 | Novo Nordisk Inc ($34.43) |
| 2020 | $564.81 | 40 | Novo Nordisk Inc ($124.14) |
| 2019 | $584.75 | 38 | AstraZeneca Pharmaceuticals LP ($123.76) |
| 2018 | $807.01 | 52 | Novo Nordisk Inc ($149.40) |
| 2017 | $655.81 | 45 | Merck Sharp & Dohme Corporation ($176.78) |
All Payment Transactions
187 individual payment records from CMS Open Payments — Page 1 of 8
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 01/25/2023 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $21.35 | General |
| Category: Diabetes | ||||||
| 12/13/2022 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $16.05 | General |
| Category: Diabetes | ||||||
| 09/28/2022 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $17.66 | General |
| Category: Diabetes | ||||||
| 09/28/2022 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $14.96 | General |
| Category: Gastroenterology | ||||||
| 05/13/2022 | iRhythm Technologies, Inc. | ZIO XT Patch (Device) | Food and Beverage | In-kind items and services | $25.89 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 03/02/2022 | iRhythm Technologies, Inc. | ZIO XT Patch (Device) | Food and Beverage | In-kind items and services | $23.76 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 02/14/2022 | Avanir Pharmaceuticals, Inc. | Nuedexta (Drug) | Food and Beverage | In-kind items and services | $14.24 | General |
| Category: pseudobulbar affect (PBA) | ||||||
| 02/03/2021 | Novo Nordisk Inc | Ozempic (Drug), RYBELSUS | Food and Beverage | In-kind items and services | $19.93 | General |
| Category: Diabetes | ||||||
| 01/27/2021 | Lilly USA, LLC | TRULICITY (Drug), JARDIANCE | Food and Beverage | In-kind items and services | $13.26 | General |
| Category: Diabetes | ||||||
| 01/27/2021 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $11.52 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 01/19/2021 | Novo Nordisk Inc | Saxenda (Drug) | Food and Beverage | In-kind items and services | $14.50 | General |
| Category: Obesity | ||||||
| 01/13/2021 | Amgen Inc. | Aimovig (Biological), Otezla, Repatha | Food and Beverage | In-kind items and services | $19.06 | General |
| Category: Neuroscience | ||||||
| 10/26/2020 | Genentech USA, Inc. | Xofluza (Drug) | Food and Beverage | In-kind items and services | $16.30 | General |
| Category: Virology & Specialty Care | ||||||
| 10/22/2020 | Amgen Inc. | Aimovig (Biological), Otezla, Repatha | Food and Beverage | In-kind items and services | $19.06 | General |
| Category: Neuroscience | ||||||
| 10/21/2020 | Merck Sharp & Dohme Corporation | JANUVIA (Drug), BELSOMRA, STEGLUJAN | Food and Beverage | In-kind items and services | $13.25 | General |
| Category: ENDOCRINOLOGY | ||||||
| 10/15/2020 | Lilly USA, LLC | BASAGLAR (Drug), TRULICITY, JARDIANCE | Food and Beverage | In-kind items and services | $14.44 | General |
| Category: Diabetes | ||||||
| 10/13/2020 | Novo Nordisk Inc | Saxenda (Drug) | Food and Beverage | In-kind items and services | $14.78 | General |
| Category: Obesity | ||||||
| 10/07/2020 | Allergan, Inc. | LINZESS (Drug) | Food and Beverage | In-kind items and services | $12.73 | General |
| Category: GASTROENTEROLOGY | ||||||
| 09/29/2020 | PFIZER INC. | CHANTIX (Drug), ELIQUIS | Food and Beverage | In-kind items and services | $13.49 | General |
| Category: NEUROSCIENCE;TOBACCO DEPENDENCE | ||||||
| 09/28/2020 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $14.05 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 09/22/2020 | Novo Nordisk Inc | Ozempic (Drug), RYBELSUS | Food and Beverage | In-kind items and services | $11.14 | General |
| Category: Diabetes | ||||||
| 09/21/2020 | Merck Sharp & Dohme Corporation | JANUVIA (Drug), BELSOMRA, STEGLUJAN | Food and Beverage | In-kind items and services | $16.45 | General |
| Category: ENDOCRINOLOGY | ||||||
| 09/18/2020 | Lilly USA, LLC | BASAGLAR (Drug), TRULICITY, JARDIANCE | Food and Beverage | In-kind items and services | $13.30 | General |
| Category: Diabetes | ||||||
| 09/11/2020 | AbbVie Inc. | CREON (Drug) | Food and Beverage | In-kind items and services | $19.25 | General |
| Category: ENDOCRINOLOGY | ||||||
| 09/02/2020 | PFIZER INC. | PREVNAR 13 (Biological) | Food and Beverage | In-kind items and services | $15.45 | General |
| Category: VACCINES | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 7 | 533 | 796 | $227,955 | $61,843 |
| 2022 | 7 | 552 | 869 | $229,046 | $67,026 |
| 2021 | 8 | 514 | 750 | $165,561 | $58,001 |
| 2020 | 12 | 598 | 893 | $108,125 | $42,407 |
Total Patients
2,197
Total Services
3,308
Medicare Billing
$229,277
Procedure Codes
34
All Medicare Procedures & Services
34 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 212 | 458 | $132,362 | $28,459 | 21.5% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 194 | 194 | $57,230 | $24,535 | 42.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 57 | 69 | $14,076 | $2,667 | 18.9% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 21 | 24 | $9,744 | $2,576 | 26.4% |
| G0402 | Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Office | 2023 | 13 | 13 | $4,901 | $1,671 | 34.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 20 | 20 | $7,500 | $1,241 | 16.6% |
| G0180 | Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 2023 | 16 | 18 | $2,142 | $692.58 | 32.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 212 | 506 | $132,931 | $32,323 | 24.3% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 183 | 183 | $50,838 | $23,329 | 45.9% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 30 | 38 | $14,168 | $3,757 | 26.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 77 | 90 | $16,124 | $3,668 | 22.7% |
| G0402 | Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Office | 2022 | 14 | 14 | $5,143 | $1,826 | 35.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 22 | 22 | $7,962 | $1,465 | 18.4% |
| G0180 | Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 2022 | 14 | 16 | $1,880 | $657.56 | 35.0% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 169 | 357 | $83,647 | $24,360 | 29.1% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 140 | 140 | $34,038 | $18,269 | 53.7% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 60 | 63 | $19,842 | $6,598 | 33.3% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 87 | 128 | $19,646 | $6,108 | 31.1% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 15 | 15 | $5,355 | $1,393 | 26.0% |
| G0180 | Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 2021 | 12 | 13 | $1,432 | $519.45 | 36.3% |
| G0179 | Physician or allowed practitioner re-certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians a | Office | 2021 | 11 | 14 | $1,101 | $387.00 | 35.1% |
| G0442 | Annual alcohol misuse screening, 15 minutes | Office | 2021 | 20 | 20 | $500.00 | $367.40 | 73.5% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 94 | 233 | $52,425 | $16,123 | 30.8% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2020 | 106 | 106 | $20,729 | $12,074 | 58.2% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 87 | 171 | $23,085 | $7,451 | 32.3% |
About Dr. Karah Coker, MD
Dr. Karah Coker, MD is a Family Medicine healthcare provider based in Athens, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/09/2011. The National Provider Identifier (NPI) number assigned to this provider is 1558656348.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Karah Coker, MD has received a total of $2,825 in payments from pharmaceutical and medical device companies, with $21.35 received in 2023. These payments were reported across 187 transactions from 25 companies. The most common payment nature is "Food and Beverage" ($2,825).
As a Medicare-enrolled provider, Coker has provided services to 2,197 Medicare beneficiaries, totaling 3,308 services with total Medicare billing of $229,277. Data is available for 4 years (2020–2023), covering 34 distinct procedure/service records.
Ad
Practice Information
- Specialty Family Medicine
- Location Athens, TX
- Active Since 06/09/2011
- Last Updated 03/31/2021
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1558656348
Products in Payments
- FARXIGA (Drug) $321.88
- Tymlos (Biological) $238.88
- Ozempic (Drug) $204.22
- XARELTO (Drug) $168.21
- JANUVIA (Drug) $147.77
- Saxenda (Drug) $147.55
- Aimovig (Biological) $144.15
- ENTRESTO (Drug) $95.10
- Repatha (Biological) $89.37
- ASMANEX (Drug) $58.25
- INVOKANA (Drug) $56.64
- BELSOMRA (Drug) $56.27
- CHANTIX (Drug) $55.22
- Victoza (Drug) $53.58
- ZIO XT Patch (Device) $49.65
- XIFAXAN (Drug) $46.75
- VRAYLAR (Drug) $45.59
- MYRBETRIQ (Drug) $39.76
- Rybelsus (Drug) $39.01
- Xofluza (Drug) $36.60
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Athens
Farris Johnson, Md, MD
Family Medicine — Payments: $30,847
Family Medicine $30,847
Timothy Law, Do, DO
Family Medicine — Payments: $18,254
Family Medicine $18,254
Dr. Henry Morris, M.d, M.D
Family Medicine — Payments: $16,624
Family Medicine $16,624
Alvin Wilson, D.o, D.O
Family Medicine — Payments: $13,833
Family Medicine $13,833
Dr. James Shiver, M.d, M.D
Family Medicine — Payments: $13,306
Family Medicine $13,306
Dr. Paul Haver, M.d, M.D
Family Medicine — Payments: $11,681
Family Medicine $11,681